HC Wainwright Reiterates Buy Rating for GRI Bio (NASDAQ:GRI)
HC Wainwright reiterated their buy rating on shares of GRI Bio (NASDAQ:GRI – Free Report) in a report released on Wednesday,Benzinga reports. Separately, Ascendiant Capital Markets cut their price objective on GRI Bio from $40.00 to $34.00 and set a “buy” rating for the company in a report on Tuesday, May 27th. Read Our Latest […]
HC Wainwright reiterated their buy rating on shares of GRI Bio (NASDAQ:GRI – Free Report) in a report released on Wednesday,Benzinga reports. Separately, Ascendiant Capital Markets cut their price objective on GRI Bio from $40.00 to $34.00 and set a “buy” rating for the company in a report on Tuesday, May 27th. Read Our Latest […]
